IL1B and neoplasm: In our CAM tumor model, we showed that IL-1β expression levels in tumor lysates of VNP20009 and PBS controls were similar (Fig. 7H), suggesting that the reduced presence of VNP20009 on tumors was insufficient to elicit the anti-tumor immune response in the CAM model.